EYE.AX
Latest Trade
0.41AUDChange
0.00(0.00%)Volume
52,700Today's Range
-
0.4152 Week Range
-
0.58As of on the Australian Stock Exchange Ltd ∙ Minimum 15 minute delay
Previous Close | 0.41 |
|---|---|
Open | 0.41 |
Volume | 52,700 |
3M AVG Volume | 2.67 |
Today's High | 0.41 |
Today's Low | 0.41 |
52 Week High | 0.58 |
52 Week Low | 0.29 |
Shares Out (MIL) | 143.69 |
Market Cap (MIL) | 59.68 |
Forward P/E | -21.03 |
Dividend (Yield %) | -- |
Nova Eye Medical Announces FY21 Trading Update
Nova Eye Medical Announces Filing Of Investigational Device Exemption Application With US FDA
Nova Eye Medical Posts FY Net Profit After Tax A$35.6 Mln
Nova Eye Medical Limited is an Australia-based medical technology company. The Company is focused on developing, manufacturing and selling a portfolio of ophthalmic treatment technologies and devices. Its technologies include iTrack minimally invasive glaucoma surgery (MIGS), which is a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patients' reliance on anti-glaucoma medications for mild-moderate glaucoma. Its Molteno3 glaucoma drainage device platform is designed to manage surgical utility and optimize clinical outcomes for long-term intraocular pressure (IOP) control in cases of severe glaucoma. The Company's 2RT is an ophthalmic laser developed for the therapy of patients in the early to intermediate stages of age-related macular degeneration (AMD).
Industry
Medical Equipment & Supplies
Executive Leadership
Victor Previn
Executive Chairman of the Board
Mike Southard
Executive Director
Simon Gray
Joint Company Secretary
Tom Spurling
Director
Alexander M. Sundich
Non-Executive Director
Price To Earnings (TTM) | -- |
|---|---|
Price To Sales (TTM) | 4.38 |
Price To Book (MRQ) | 1.67 |
Price To Cash Flow (TTM) | -- |
Total Debt To Equity (MRQ) | 10.47 |
LT Debt To Equity (MRQ) | 4.98 |
Return on Investment (TTM) | -6.24 |
Return on Equity (TTM) | -5.49 |
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.